Curis Lifesciences Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Curis Lifesciences Ltd is ₹ 121 as of 05 May 15:30 . The p/e ratio of Curis Lifesciences Ltd changed from 0 to 0 over 6 quarters. This represents a CAGR of 0.0% The p/e ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 to 0 over 5 quarters. This represents a CAGR of -100.00% The market cap of Curis Lifesciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The market cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The Revenue of Curis Lifesciences Ltd is ₹ 9.12 crore as of Jun '24 .The Revenue of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Curis Lifesciences Ltd is ₹ 2.73 crore as of Jun '24 .The EBITDA of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Curis Lifesciences Ltd is ₹ 1.2 crore as of Jun '24 .The Net Profit of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of Jun '24 . The dividend payout of Curis Lifesciences Ltd changed from 0 % to 0 % over 6 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % to 0 % over 6 quarters. This represents a CAGR of -100.00% .

About Curis Lifesciences Ltd

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010.
Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.
Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar. Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic.

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

FAQs for the comparison of Curis Lifesciences Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Curis Lifesciences Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Curis Lifesciences Ltd is 97 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 10,577 Cr

What are the key factors driving the stock performance of Curis Lifesciences Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Curis Lifesciences Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Curis Lifesciences Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 5, 2026, the Curis Lifesciences Ltd stock price is INR ₹121.0. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4592.6.

How do dividend payouts of Curis Lifesciences Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Curis Lifesciences Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.